Kofoed, Søren Vester
Barrio-Calvo, Marina
Pavlidis, Michail Angelos
Kleine-Kohlbrecher, Daniela
Lausen, Mads
Lunabjerg-Vestergaard, Cherie
Viborg, Nadia
Garde, Christian
Rønø, Birgitte
Friis, Stine
Article History
Received: 31 March 2025
Accepted: 17 June 2025
First Online: 24 July 2025
Change Date: 11 September 2025
Change Type: Update
Change Details: Four of the headers were formatted incorrectly as normal text have been updated
Declarations
:
: All authors of this manuscript are currently employed by EVAXION, a techbio company that develops vaccines with the intention of commercialization. EVAXION is listed on the American stock exchange, Nasdaq. As employees of EVAXION, we have a financial interest in the success of the company and its products. This interest may influence the interpretation and presentation of the research findings.